About three million people globally are ‘missed’ each year for Tuberculosis diagnosis. Many of them will die, some will get better, others will continue to infect others.
To tackle TB a dynamic change in discourse is needed. The focus must be on how to respond to emerging complexities the disease presents.
Antibiotics that were not originally earmarked to treat TB have shown the first signs of effectiveness and could be added to the much-needed arsenal of drugs to fight the deadly disease.
South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.